Pharma: Other News To Note
Tuesday, April 17, 2012
Conformetrix Ltd., of Manchester, UK, and AstraZeneca plc, of London, signed a research collaboration agreement allowing AstraZeneca to apply Conformetrix's NMR-based technology across its preclinical therapeutic pipeline to enhance lead discovery and hit identification.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.